The spatial and temporal expression of seven Drosophila protein tyrosine phosphatase genes during oogenesis was examined by whole mount in-situ hybridization of antisense RNA probes to ovaries. Our observations indicate diverse expression patterns consistent with multiple roles for protein tyrosine phosphatases in the ovary. DPTP99A and corkscrew transcripts are expressed in follicle cells, consistent with possible roles in the EGF receptor signaling pathway. Transcripts from corkscrew and DPTPIOD are detected in the germline during oogenesis and localized to the oocyte during egg chamber development. Localization of the two transcripts is disrupted by mutations in egalitarian and Bicaudul D. DLAR and DPTP4E transcripts are found in the germline during the same developmental stages as DPTPlOD transcripts, but their transcripts are not localized to the oocyte. DPTP6lF transcription is detected only after stage 6 of oogenesis. After stage 10B these transcripts are transported to the oocyte; thus ovarian transcription of DPTP61F may reflect a maternal contribution of the mRNA for later use during embryogenesis. DPTP69D transcripts are sequestered in the nucleus from stage 7 to stage 10, and then released to the cytoplasm. Our observations suggest that the export of DPTP69D mRNA from the nucleus is temporally regulated during oogenesis.
Introduction
Tyrosine phosphorylation, catalyzed by protein tyrosine kinases (PTKs), is an important regulator of developmental processes. Recent work highlights the importance of protein tyrosine phosphatases (PTPs) in PTK signaling pathways where they may either activate or inactivate other molecules in the pathway and thus may be seen as either inhibitors or activators of signaling, depending upon their context (Fischer et al., 1991; Brautigan, 1992; Walton and Dixon, 1993; Mourey and Dixon, 1994) .
We are interested in the role of PTPs during Drosophila oogenesis and early embryogenesis.
Two well characterized PTK signaling pathways, defined by the genes
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remaining 15 cells will undergo 8 to 9 rounds of endomitosis to become the polyploid nurse cells. Prior to leaving the germarium, the entire germ cell cluster is enveloped by a somatically derived follicle cell epithelium to form the egg chamber. As egg chambers mature they move in a posterior direction through the ovariole, into a region called the vitellarium. The vitellarium typically contains 6 to 8 egg chambers arranged from anterior to posterior in order of increasing maturity. Within the egg chamber the oocyte will become metabolically quiescent, but the nurse cells remain active and synthesize cytoplasmic constituents for transport to the oocyte. This transport occurs gradually during much of oogenesis, but during stage 10 it enters a rapid phase that results in the transfer of virtually all remaining cytoplasm from the nurse cells to the oocyte. The nurse cells subsequently degenerate. As the oocyte matures the follicle cells undergo a series of migrations within the egg chamber, and during later stages they will secrete the multiple layers of the egg shell.
The activities of the different cell types in the egg chamber are spatially and temporally coordinated with each other, in a process the requires intercellular signaling. TOP, which is the Drosophila homolog of the vertebrate EGF receptor (Price et al., 1989; Schejter and Shilo, 1989 ) is required in the follicle cells to transduce a signal thought to originate in the oocyte (Schupbach, 1987; Price et al., 1989; Neuman-Silberberg and Schtipbach, 1993) . This signal regulates the spatial identity of the follicle cells, and eventually leads to the establishment of the dorsal/ventral coordinates of the egg chamber, and of the egg and embryo that ultimately develop from the egg chamber (Schtipbach, 1987) . Many of the components of the TOP signaling pathway have been identified (Simon et al., 1991; Doyle and Bishop, 1993; Neuman-Silberberg and Schiipbach, 1993, Tsuda et al., 1993; Brunner et al., 1994) , but to date it is unclear what PTPs participate in this process.
The tor gene is transcribed in the germ cells of the ovary (Sprenger et al., 1989) . Mutations in torso (tor) produce a maternal effect embryonic lethal phenotype, associated with defects in the head and tail structures of embryos that develop from eggs derived from homozygous tor females (Schiipbach and Wieschaus, 1986) . The expression of the PTP gene corkscrew (csw), is also required in the germ cells of the ovary, for positive transduction of the TOR signal during embryogenesis (Perrimon et al., 1985; Perkins et al., 1992) It has been suggested, based on a genetic interaction between top and csw, that csw may also function in the top signaling pathway (Simon et al., 1991) . However this genetic interaction is only observed between the dominant alleles topElt ' and cswE(sev)lA. Thus the extent of csw involvement in normal top signaling remains unclear.
In addition to csw, two other PTP genes are expressed during Drosophila oogenesis. The genes string (stg) and mine (me) encode soluble PTPs homologous to the cdc25 phosphatase of S. pombe (Edgar and O'Farrell, 1989; Alphey et al., 1992; Courtot et al., 1992) . Expression of twe is required in the germ line during oogenesis for the proper assembly of the meiotic spindle and the arrest of the developing oocyte at metaphase I (Alphey et al., 1992; Courtot et al., 1992) . Transcripts from stg are synthesized in the nurse cells for transport to the oocyte via the ring canals. These maternally contributed transcripts are required during embryogenesis for the regulation of the early nuclear divisions of the syncitial embryo (Edgar and O'Farrell, 1989) .
There is some indication that other PTK and PTP genes will be required during oogenesis. For instance, anti-phosphotyrosine antibodies stain one or more components that are present in ring canals throughout oogenesis, indicating that tyrosine phosphorylation may play a role in ring canal assembly (Robinson et al., 1994) .
We wished to identify additional PTPs that are transcribed in the ovary, and to determine their spatial and temporal expression patterns, with the expectation that their expression patterns may provide an indication of their roles in oogenesis. We have used a PCR based screen to isolate 7 PTP gene fragments from Drosophila ovarian cDNA: DPTP69D, DLAR, DPTP4E, DPTPIOD, DPTP99A , DPTP61F, and a novel gene we will refer to as DPTP36E. Although the first six of these genes have been previously described, none of them have been reported to be expressed in the ovary. We have used in situ hybridization to determine the time and location of RNA expression of DPTP69D, DLAR, DPTP4E, DPTPIOD, DPTP99A and DPTP6IF in ovaries. Although we did not recover csw in our screen, we included it in our analysis because of the genetic evidence that CSW acts in the TOR and TOP signal transduction pathways (Simon et al., 1991; Perkins et al., 1992 ). Thus we expected that csw might be expressed in the follicle cells of the developing egg chamber at the times and locations where top is thought to be active.
Our observations indicate that only two of the known PTPs, DPTP99A and csw, accumulate to detectable levels in follicle cells, starting at oogenesis stages 9 and 11, respectively. We also report that csw and DPTPIOD transcripts are localized to the oocyte in processes that depend on the activity of the Bicaudel D (BicD) and egalitarian (egl) genes, and that transcripts from DPTP69D accumulate in the nurse cell nuclei for a minimum of 10 h before they are released to the cytoplasm. We discuss the possible roles of these PTPs in oogenesis.
Materials and methods

Drosophila stocks
Wild type stocks used were Oregon R and Canton S. Mutant strains used were the following: of 30 s at 94OC, 30 s at 53OC, and 2 min at 72OC. After Siiter). Deficiency strains were obtained from the the last cycle an extension of 10 min at 72OC was perBloomington stock center.
formed.
PCR isolation of PTP fragments
Ovarian mRNA was isolated as follows: 3-5 day old female flies were fed live yeast for 24 h, then ovaries were removed by dissection. Total RNA was prepared by grinding ovaries in 1% SDS/10 mM EDTA, followed by extraction with phenol/chloroform and treatment with DNase 1. cDNA was synthesized by reverse transcription using AMV reverse transcriptase (Pharmacia) according to the manufacturer's instructions. This cDNA was treated with RNase A and then used as a template for PCR amplification using primers designed from conserved regions in PTP catalytic domains. These primers were as follows: primer 562:
(corresponds to the complement of the coding sequences for amino acids HCSAGV); primer 854:
(corresponds to the coding sequences for amino acids DFWRMIWE);
(corresponds to the complement of the sequences coding for amino acids GVGRTG); primer PCR 2: 35 cycles of 30 s at 95OC, 90 s at 42OC and 2 min at 72OC, followed after the last cycle by an extension of 10 min at 72OC.
PCR 3: (Nested PCR) 4 cycles of 30 s at 95OC, 90 s at 37OC and 2 min at 72OC, then 4 cycles of 30 s at 95OC, 90 s at 43°C and 2 min at 72OC, and 30 cycles of 30 s at 95OC, 90 s at 53OC and 2 min at 72OC were performed with primer set 1 (see Table 1 ). After the last cycle an extension of 10 min at 72OC was performed. The PCR products from the first round of amplification were gel purified, then amplified using primer set 2 for 35 cycles of 30 s at 95OC, 90 s at 43OC and 2 min at 72OC, followed by an extension of 10 min at 72OC.
PCR 4: 4 cycles of 45 s at 95OC, 90 s at 43OC and 90 s at 72OC were followed by 30 cycles of 45 s at 95OC, 90 s at 53OC and 1 min 30 s at 72OC and the 10 min extension at 72OC.
PCR products of the expected size (approximately 380 bp) were gel purified and cloned into Bluescript KS+ vectors (Stratagene) by the T-tailing method of Marchuk et al. (1991) . The PTP gene fragments yielded by each protocol are shown in Table 1. 2.3. Nucleotide sequencing DEGEN 1, 2, 3, 4 and GXG were kindly provided by F. Jirik. cDNA from five pairs of ovaries was amplified by PCR. Each reaction contained 100 pmoles of each primer in a buffer containing 50 mM KCl, 10 mM TrisHCl (pH 9.0), 0.1% Triton-X-100 and 200pM of each dNTP and 2.5 U of Taq polymerase (Perkin Elmer). The PCR protocols used were as follows:
Plasmid DNA was prepared using Magic minipreps (Promega) and insert fragments were sequenced by the method of Sanger et al. (1977) with T3 and T7 primers using a Sequenase Version 2.0 sequencing kit, or by thermal cycle sequencing using an ABI Dye Primer cycle sequencing kit according to the manufacturer's instructions. DNA sequence was translated and the predicted peptide sequence compared to known Drosophila PTPs. Peptides that did not match known Drosophila PTPs were searched against entries in the nonredundant peptide sequence database using the BLAST server at the National Center for Biotechnology Information.
Polytene in situ hybridization
PCR 1: Temperature cycles were 5 min at 94oC ('hot start') followed by addition of Taq polymerase, 30 cycles Digoxygenin labeled DNA probes were prepared from DLAR and DPTP36E gene fragments by PCR, essentially as described by Lion and Haas (1990) . The PCR 1 protocol (above) was followed, using 1 ng of the appropriate The PCR products were electrophoresed on a 1.5% agarose gel and recovered from the agarose by the method of Heery et al. (1990) . The probes were then hybridized to Canton S polytene chromosomes as described by de Frutos et al. (1990) .
RNA probes
RNA probes were prepared following the digoxigenin RNA labeling reaction protocol provided by Boehringer Mannheim and modified by use of only 10 U of either T3 or T7 RNA polymerase (Stratagene) and the addition of 40 U of RNase Inhibitor (Boehringer) per reaction. After the transcription step, the RNA was hydrolyzed in carbonate buffer (60 mM Na$Os, 40 mM NaHCOs) at 65OC for 40 min. Sense and antisense riboprobes were prepared from each PTP gene fragment clone. The template for csw riboprobes was kindly provided by L. Perkins. For some experiments riboprobes for DPTP99A were made from a full length cDNA clone, kindly provided by W. Chia.
In situ hybridizations to ovaries
In situ hybridization to ovaries was performed using sense and antisense digoxigenin labeled RNA probes from each of the PTP gene fragments. The hybridizations were performed essentially as described by Tautz and Pfeiffle (1989) , with modifications described by Stiter and Steward (1991) . For detection of RNA in late stage oocytes, proteinase K treatment was increased to lOOpg/ml proteinase K for 1 h. In the case of DPTP99A, we observed high levels of background staining when using both the sense and the antisense riboprobes. To reduce the background signal we performed a ribonuclease digestion just prior to incubation with the antidigoxigenin antibody. Ovaries were incubated in PBT buffer containing 100 U/ml ribonuclease Tl (BRL) at 37'C for 30 min, and rinsed 2 x 1 min and 2X 20 min with PBT. The remainder of the protocol was unchanged.
We estimate that RNase treatment reduced non-specific background staining by approximately 90%.
Results
Isolation of PTP gene fragments from ovarian cDNA
Fragments from seven different Drosophila PTP genes were isolated by reverse transcription (RT) of ovarian RNA, followed by PCR with degenerate primers directed against conserved regions of PTP catalytic domains. Several protocols were used, with different primer sets, and each protocol yielded different PTP fragments (Table 1) . Six of the PTP genes recovered in our screen, DEAR,
DPTP4E.
DPTPIOD, DPTP61 F, DPTP69D, and DPTP99A , have been previously described, but none of them have been reported to be expressed in the ovary. In addition, a fragment corresponding to the catalytic domain of a novel PTP gene was recovered.
The chromosomal location of the novel DPTP was determined by in situ hybridization of a cDNA fragment to polytene chromosomes.
The hybridization signal was localized to cytological position 36E. We designate this putative PTP DPTP36E, in accordance with standard nomenclature. DLAR has been reported to map to cytological position 36C3-36D2 in the cytogenetic map in Lindsley and Zimm (1992) . To determine the cytological position of DPTP36E relative to DUR, we performed in situ hybridization with a DEAR probe. DLAR hybridization was detected at position 38A, and not in the vicinity of 36 D-E. The cytogenetic localizations were confirmed by Southern hybridization, using genomic DNA from flies heterozygous for deficiencies that remove the regions in which the PTPs were thought to reside. Southern hybridization signal intensities were compared to a control probe specific for another region of the chromosome. A 50% reduction in signal relative to the control probe indicated that the PTP gene of interest was removed by the deficiency. Sequences complimentary to the DLAR probe are removed by Df(2L)VA12 (37C2-5; 38B2-Cl) and Df (2L)TW84 (37F5-38Al; 39D3-El), but are not removed by Df(2L)TW1(38A7-Bl; 39C2-3). These results limit the DLAR gene to the interval 37F5-38Al; 38A7-B 1, consistent with our assignment of the gene to cytological position 38A by in situ hybridization.
Sequences complimentary to the DPTP36E probe are removed by Df(2L)H20 (36A8-9; 36E3-4) and Df (2L)M36F-S5 (36Dl-El; 36Fl-37Al) in agreement with our assignment of the gene to position 36E. The characterization and expression of DPTP36E will be reported elsewhere.
Ovarian expression of Drosophila PTPs
The PTPs we recovered from RT-PCR represent a diverse family of molecules that contain other functional domains in addition to the conserved PTP catalytic domains (Table 2) . With the exception of DPTP61F, all of the PTPs recovered contain a transmembrane domain and an extracellular domain that may serve as a ligand binding domain. These receptor-like PTPs (R-PTPs) can be classified based on their extracellular domains (Fischer et al., 1991) . DLAR and DPTP69D are classified as type II R-PTPs, because each one contains repeated immunoglobulin G-like (ICC-like) domains and fibronectin type III-like (FN III-like) repeats in their extracellular domains (Streuli et al., 1989; Fischer et al., 1991) . DPTP4E, DPTPlOD, and DPTP99A are classified as type III RPTPs because they have only FN III-like repeats in their extracellular domains (Fischer et al., 1991; Hariharan et al., 1991; Tian et al., 1991; Yang et al., 1991; Oon et al., 1993) . DPTP61F is a nonreceptor-like PTP that is expressed in two isoforms, that are generated by alternative splicing and are targeted to different subcellular locations Alphey et al., 1992; 3, Courtot et al., 1992; 4, Perrimon et al., 1985; 5, Perkins et al., 1992; 6. Streuli et al., 1989; 7, Tian et al., 1991; 8, Yang et al., 1991; 9, Oon et al.. 1993; 10, McLaughlin and Dixon, 1993; 11, Desai et al., 1994; 12, Hamilton et al., 1995; 13, Hariharan et al., 1991. ( McLaughlin and Dixon, 1993) . These structural distinctions may indicate that the different PTPs perform distinct cellular and/or developmental functions. As a first step in evaluating possible PTP functions in the ovary, we have examined the temporal and spatial accumulation of PTP mRNAs in ovarian tissue. Although we did not recover fragments of the csw gene in our screen, we obtained a probe from L. Perkins (MGH, Boston, MA), and included it in our experiments, because it has been implicated in the TOP signal transduction pathway (Simon et al., 1991) . We performed whole-mount RNA in situ hybridizations to ovaries and found that all of the PTPs are expressed in ovaries but in somewhat different patterns.
3.3. DPTP61F RNA is detected in nurse cells from mid oogenesis until stage 10 DPTP6IF transcription is first detected at approximately stage 6 in the nurse cells, as indicated by very faint staining.
Transcripts gradually accumulate until stage 10, when there is a marked increase in the intensity of staining observed (Fig. 1A) . The transcript is not detected in the oocyte until stage 10B. During stages 11 and 12, the transcript is transferred into the oocyte, completely leaving the nurse cells by stage 13 (Fig. lB-D) .
DPTP4E, DLAR and DPTPlOD have very similar expression patterns
DLAR transcription is first detected in region 2b of the germarium ( Fig. 2A) . The transcript appears in both nurse cells and oocyte, and staining intensity increases until stage 6. In the oocyte, staining intensity decreases from stage 7-9, after which the transcript is no longer detectable in the oocyte. In nurse cells, staining is observed continuously until stage 10, when very intense staining is apparent. During stages 11 and 12, the transcript is transferred from the nurse cells to the oocyte as is observed for DPTPBlF mRNA above (data not shown; but similar to Fig. lB-D) . DPTP4E expression is first detected in region 2b of the germarium and its accumulation pattern is indistinguishable from that of DLAR (see Fig. 2A ). The riboprobes used for detection of DPTP4E or DLAR transcripts are not expected to cross-hybridize as their nucleic acid sequences, even in the catalytic domains, are not highly similar. For example, the portions of the catalytic domains of DPTP4E and DLAR used to make the riboprobes are 49% identical, and the probes gave identical expression patterns; the portions of the DPTP4E and DPTPIOD genes used for making the hybridization probes are 71% identical and did not give identical patterns. However, to test directly for cross-hybridization, we used the same DPTP4E and DLAR probes to examine RNA expression in embryos. The expression patterns in embryos for the two genes are reported to be distinct (Yang et al., 1991; Oon et al., 1993) . There was no indication of cross hybridization between our two probes, as the embryonic expression patterns we obtained for the two probes were different, and were in accordance with those described for DPTP4E and DL4R in the literature (data not shown).
Therefore, DPTP4E and DEAR are expressed at the same time and place in ovaries, but in different patterns in embryos.
DPTPIOD transcription is detected initially in region 2b of the germarium and its expression is temporally similar to that of DPTP4E and DUR. However the distribution of the RNA within the egg chamber is distinct.
DPTPlOD transcripts accumulate preferentially in the oocyte from stage 4-8 (Fig. 2B,C) . During stages 6-7 the transcripts appear to be localized to the posterior pole of the oocyte and during stage 8 they are transiently redistributed to the anterior margin (Fig. 2C) . During stage 9 the transcripts in the oocyte disburse, and are no longer detected. Meanwhile nurse cell staining intensity increases during stages 8-10, and starting in stage 11 the transcript is transferred from the nurse cells to the oocyte and appears to be uniformly distributed there (data not shown; similar to DPTP6ZF, Fig. lB-D) .
csw RNA is localized to the oocyte and in later stages to follicle cells
Transcripts from csw are first detected in the germarium. In region 2a, two or more clusters of 16 germ cells span the width of the germarium. One cell in each cluster, presumably the pro-oocyte, was seen to stain darkly for csw RNA (Fig. 3B) . In region 3 of the germarium (stage 1 of the vitellarium), strong csw RNA accumulation is detected in the oocyte, which is now located in the posterior of the egg chamber (Fig. 3B) . Preferential accumulation in the oocyte continues until stage 10 of oogenesis, when increased levels of staining are detected in the nurse cells (Fig. 3C) . After prolonged treatment of ovaries with proteinase K, to permeablize the newly deposited vitelline membrane, csw transcripts are also strongly detected in stage 10-14 oocytes (data not shown). Transcription of csw is detected in the cytoplasm of the follicle cells during stages 11-13 (Fig. 3A) . With the exception of DPTP99A (see below), csw is the only PTP gene for which we clearly detect transcription in follicle cells.
The early accumulation of DPTPIOD and csw transcripts in the developing oocyte is similar to that observed for a number of other genes, including fs(l) KlO (Cheung et al., 1992) , oskar (osk; Ephrussi et al., 1991; Kim-Ha et al., 1991) 0018 RNA binding (orb; Lantz et al., 1992) and gurken (grk; Neuman-Silberberg and Schiipbach, 1993) . Several of these transcripts depend on the activity of BicD and egalitarian (eg!) for their localization (Siiter and Steward, 1991; Lantz et al., 1992; Ran et al., 1994) . To determine whether this is also true of csw and DPTPIOD transcripts, we performed in situ hybridizations on ovaries from females mutant for either BicD or egl. We used females transheterozygous for two alleles of BicD: BicDPA6V BicDRz6; and females bearing one mutant allele of BicD (PA66) and a deficiency which deletes BicD (Df(2L) 119). In both cases, DPTPIOD transcripts were present, but there was no specific localization to one cell of the I6 cell cyst (Fig. 4B , and data not shown). This was also true for csw transcripts (Fig. 4D , and data not shown). Two allele combinations were used for egl as well: eglRc12/eglwu50 and eglWu50/Df(2R)bw5. In ovaries from females of either genotype, DPTPIOD transcripts were present but unlocalized (Fig. 4A , and data not shown), and the s&me was true of csw transcripts (Fig. 4C , and data not shown). In egl mutant ovaries, there appeared to be less of an accumulation of DPTPlOD transcripts, as the staining intensity was much lower than that in the BicD ovaries despite the experiments being performed in parallel, with the same amount of probe and the same staining time (compare Fig. 4A and B). This was not the case for csw (compare Fig. 4C and   D) . 
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DPTP99A RNA is expressed in the germline and the follicle cells
DPTP99A RNA is detected in the germ cells of the germarium, region 2b or 3 and remains present in the nurse cells throughout oogenesis (data not shown). During stages 10-12, strong staining is visible in the follicle cells surrounding the oocyte (not shown, but similar to figure 3A ). In some egg chambers faint staining can be detected in the follicle cells as early as stage 9.
DPTP69D RNA is detected in stage 7 of oogenesis and is observed in prolonged association with nurse cell nuclei
DPTP69D transcription is first detected in stage 7 of oogenesis, as a tiny spot of stain deposition within each of the 15 nurse cell nuclei (Fig. 5A, arrows) , however the transcripts cannot be detected in the cytoplasm.. This pattern persists, with spots of increasing size and intensity in the nuclei until stage 9 (Fig. 5B) . During stage 10 cytoplasmic staining becomes apparent (Fig. 5A ) and increases until late stage IOB, when cytoplasmic staining becomes very intense -making it difficult to determine whether any transcript remains in the nurse cell nuclei (Fig. 5C ). At this stage, the transcript appears to be more concentrated near the nurse cell-oocyte boundary ( Fig.  5C; arrowhead) . By stage 11, the staining intensity in the nurse cell cytoplasm is greatly reduced and transcript can again be detected in the nurse cell nuclei (data not shown). Nuclear staining is observed up to late stage 12, when only a few nurse cell nuclei are visible, and each has a small spot of stain with no staining apparent in the remaining cytoplasm (Fig. 5D ). The nuclear staining is always localized to small regions within the nurse cell nuclei; thus, it appears that the transcripts are sequestered in a specific region of the nucleus.
Discussion
All known Drosophila PTPs are transcribed during oogenesis
We have isolated 7 PTP gene fragments in a PCR screen of ovarian cDNA. One (DPTP36E) is novel; the others have been described previously but not reported as being expressed in the ovary. Here, we report the spatial and temporal transcript accumulation patterns of 6 of these PTP genes, as well as that of csw, in Drosophila ovaries as determined by in situ hybridization.
Including stg and twe, this brings the total of known Drosophila
PTPs to 10, all of which are transcribed during oogenesis. The varied accumulation patterns of mRNAs transcribed from these PTP genes are consistent with multiple distinct functions during oogenesis.
DPTP6IF RNA is detected beginning in midoogenesis, and is translocated to the oocyte after stage 10
DPTP61F transcript is only detected in nurse cells in stage 6-10 egg chambers, with much stronger staining evident in stage 10. During stages 10-13 the transcript is transported into the oocyte. This is a pattern which would be expected of an mRNA that will be stored in the oocyte for use during early embryogenesis. However, it is also possible that DPTP61F performs some role in late oogenesis.
Alternative splicing leads to two different forms of the DPTP61F protein which are localized to either the cytoplasm (reticular network and mitochondria-like organelles) or the nucleus in tissue culture cells (McLaughlin and Dixon, 1993) . Our RNA probe, composed only of the catalytic domain, could not be used to distinguish between the two transcript forms; thus our data do not address whether only one form or both are transcribed in the ovaries.
DPTP$E, DLAR and DPTPJOD show similar expression patterns
The expression patterns of DPTP4E, DLAR, and DPTPIOD are similar. Transcripts from all three genes are detected in the germ cells of the germarium and in nurse cells up to stage 10. The transcripts of DPTP4E and DLAR are observed in both nurse cells and oocyte until stage 6, followed by an apparent clearing of transcript from the oocyte during stages 7-9. In stage 10 and later egg chambers, the transcript is again observed entering the oocyte at a time similar to that expected for transcripts that are stored for later use in the developing embryo. This biphasic pattern of expression in the oocyte may indicate that the gene products function during oogenesis and again as maternal contributions to embryogenesis.
The pattern of DPTPIOD expression is similar to DPTPIE and DEAR, but with a period (stages 4-8) during which localization to the oocyte is observed. This localization is similar to that of many other mRNAs that are localized to the oocyte during early oogenesis, including BicD, fs(l) KlO , gurken, hu-li tai shao, orb, and osk (Siiter et al., 1989; Ephrussi et al., 1991; Kim-Ha et al., 199 1; Cheung et al., 1992; Lantz et al., 1992; Yue and Spradling, 1992; Neuman-Silberberg and Schtipbach, 1993) . Like DPTPlOD mRNAs, transcripts from each of these genes are initially concentrated near the posterior of the oocyte and are redistributed to the anterior margin during stage 8 of oogenesis. The anterior localization of osk , orb, and grk transcripts is transient, as is observed for DPTPIOD. With the possible exception of DPTPlOD, all of these genes provide activities that are required for egg chamber development and/or the generation of asymmetries in the oocyte (Wieschaus, 1979; Lehmann and Niisslein-Volhard, 1986; Mohler and Wieschaus, 1986; Schiipbach, 1987; Yue and Spradling, 1992; Christerson and McKearin, 1994; Lantz et al., 1994) . The similar specialized localization of DPTPIOD transcripts during stages 7-8 may imply that it also participates in some aspect of egg chamber maturation.
Aside from the localization of DPTPIOD transcripts, the expression patterns of DPTPIE, DLAR and DPTPIOD are similar. Oon et al. (1993) have observed that DPTPlOD and DPTP4E show a high degree of similarity in their catalytic domains and have similar intron/exon structures. They suggest that the two genes have arisen by gene duplication.
Their structural similarities together with their temporally similar expression patterns could indicate that the two genes retain similar or redundant roles in oogenesis. Based on its similar transcript expression pattern, DLAR could also provide functions similar or redundant to DPTP4E or DPTPIOD in oogenesis. All three R-PTPs contain multiple fibronectin type III domains in their extracellular regions. However DLAR is less similar to DPTP4E and DPTPlOD in other respects: in addition to its FN III-like repeats, DLAR contains 3 IGG-like domains in its extracellular region, and it contains two PTP catalytic domains, while DPTP4E and DPTPlOD each contain only one catalytic domain. These structural distinctions suggest that DEAR may have diverged functionally as well as structurally.
Localization of DPTPIOD and csw mRNAs to the oocyte during early oogenesis
Although DPTPIOD transcripts are present in region 2b of the germarium, they are not localized until stage 4 in the vitellarium. In this respect DPTPIOD transcripts are similar to those from fs(l)KIO, and staufen, which are uniformly distributed in the germ cells for some time before they are localized to the oocyte during vitellarium stages 2 and 6 respectively (Siiter and Steward, 1991; St. Johnston et al. 1991) . Thus the transport of DPTPIOD transcripts to the oocyte may require a unique factor, to facilitate its localization starting in stage 4. Alternatively DPTPIOD transcripts may have a lower affinity for some common transport or localization factor that is saturated by other higher affinity transcripts prior to stage 4.
Transcripts from csw are localized to a single cell of the germarial cyst in region 2a of the germarium, presumably the prospective oocyte, and are detected in the oocyte throughout the vitellarium. As mentioned above, the preferential accumulation of transcripts to the presumptive oocyte in the germarium is also observed for transcripts from many other genes, many of which are known to provide activities that are required for egg chamber development prior to fertilization. However, the established function for CSW in the germline is transduction of the TOR signal during embryogenesis (Perkins et al., 1992) . Thus it is not apparent why csw transcripts should be expressed and localized to the oocyte in the germarium. One interpretation would be that csw may serve another, as yet undefined, function during early oogenesis. The twisted phenotype associated with embryos that develop in a csw mutant germline may also indicate other germline functions for CSW in addition to its role in TOR signaling. 4.5. BicD and egl are required for localization of the csw and DPTPIOD transcripts csw transcripts fail to accumulate in the pro-oocyte in ovaries mutant for either BicD or egl, even in very early stages of oogenesis. Transcripts from osk and orb also require BicD and egl for their localization (Ran et al., 1994) . However some hypomorphic BicD mutant backgrounds, such as BicD BicDPA66/BicDs26, still contain enough localization activity to direct osk and orb transcripts to the oocyte during early stages (Siiter and Steward, 1991; Lantz et al., 1992; Ran et al., 1994; B. Stiter, personal communication) .
Localization of csw transcripts is more sensitive to a reduction of BicD activity, in that transcripts fail to localize in BicDPA66/BicDs26 mutant ovaries (Siiter and Steward, 1991) . This may indicate that csw transcripts have a lower affinity for some localization factor, as compared to orb or osk RNAs, or that csw RNA localization requires an additional factor that fails to associate with a localization complex in BicD hypomorphs.
The localization of DPTPIOD transcripts to the oocyte also depends on both BicD and egl function, since localization is abolished in ovaries from females mutant for either of these genes. The transcript abundance of DPTPIOD in egl mutant ovaries appears to be reduced relative to that in the BicD mutant ovaries, which were stained under the same conditions. This raises the possibility that the DPTPIOD RNA is transcribed less abundantly or that it is less stable in egl mutant backgrounds.
csw is expressed in follicle cells
csw transcripts are observed in follicle cells during oogenesis stages 11-13. This places csw expression where one would expect to find downstream effecters of the TOP signaling pathway (Kammermeyer and Wadsworth, 1987; Schiipbach, 1987; Price et al, 1989; Katzen et al., 1991) . It has been suggested that CSW may function downstream of the TOP receptor during oogenesis (Simon et al., 1991; Brand and Perrimon, 1994) . In addition, csw has been isolated in a screen for modifiers of sevenless (Simon et al., 1991; Tsuda et al., 1993 ) and thus appears to function as part of the cassette common to a number of pathways involving receptor tyrosine kinases (Perrimon, 1993) . If csw participates in TOP signal transduction during oogenesis, the apparent lack of csw mRNA in follicle cells prior to stage 11 is notable because TOP is thought to participate in a process that results in the spatially asymmetric deposition of embryonic pattern determinants that are built into the vitelline membrane (Schupbach et al., 1991; Stein et al., 1991; Roth, 1993; Roth and Schiipbach, 1994) . However, the vitelline membrane is secreted over most of the oocyte during stages 9 and 10 of oogenesis (King, 1970) , before any csw RNA can be detected. Thus either csw is not expressed in the follicle cells prior to stage 11, or it is expressed at levels too low for us to detect. TOP is also required for specification of pattern in the multi-layered chorion, which is secreted by the follicle cells during stages 11-13 (Schiipbach, 1987; King, 1970) . The contribution of top to the patterns of the chorion and the oocytelembryo can be separated in some genetic backgrounds. Eggs produced by top mutant females with brainiac (brn) mutant germlines have ventralized chorions, but produce embryos with normal dorsal/ventral patterns (Goode et al., 1992) . The time at which TOP activity is required for the chorion pattern has not been established, but transcripts persist at least through stage 10B (Kammermeyer and Wadsworth, 1987) . The later appearance of csw expression may indicate that CSW action with respect to TOP is limited to functions associated with the pattern of chorion secretion. Thus we suggest that if CSW plays a role in the TOP signaling pathway during oogenesis, it may function only in the capacity of TOP to specify the pattern of the chorion. This interpretation is supported by recent observations that a follicle cell epithelium mutant for a severe allele of csw results in eggs with ventralized chorions and embryos with normal dorsal/ventral patterns (L. Perkins, personal communication) , similar to those from the toplbrn mosaic females.
DPTP99A transcript is present in follicle cells during late oogenesis
While all of the PTP transcripts we have examined are expressed in the germline cells of the egg chamber, only two, csw and DPTP99A, can also be detected in follicle cells. As discussed above for csw, top is thought to act in the follicle cells to influence the deposition of spatial cues in the vitelline membrane, and then possibly again later to facilitate a series of follicle cell migrations that lead to the final pattern of the chorion. Since small amounts of DPTP99A transcripts are first detected in stage 9, and are abundant in stage 10, it is possible that the DPTP99A gene product may participate in the TOP pathway during vitelline membrane synthesis. However, flies that are homozygous null for DPTP99A are viable and fertile, with no visible defects (Hamilton et al., 1995) . Thus DPTP99A is a non-essential gene, and is perhaps redundant with other PTPs. Since our data do not indicate transcription of any of the other known PTPs in the follicle cells prior to stage 11 of oogenesis, we suggest that additional, currently unidentified PTPs may be expressed in the follicle cells.
4.8. DPTP69D transcript is associated with nurse cell nuclei for a prolonged period during oogenesis DPTP69D mRNA is first detected in stage 7 of vitellogenesis. The transcripts are restricted to a region within the nucleus of each nurse cell and are apparently not released until stage 10A. This has not been observed for any of the other PTP genes and may reflect a novel form of regulation of expression for DPTP69D . We observe the apparent sequestration of DPTP69D transcript (for a minimum of 10 h and a maximum of 24 h, according to the approximate durations of the stages as listed by King, 1970) , followed by a relatively abrupt release of the message.
The manner in which the RNA is retained in the nucleus suggests that its release from the nucleus may be regulated in a developmentally specific manner as has been suggested for other mRNAs (Showman et al., 1982; DeLeon et al., 1983) . We suggest that this nuclear retention may be a mechanism for the accumulation of large quantities of mRNA or pre-mRNA, followed by rapid release of the mRNA to the cytoplasm, which could result in the rapid synthesis of a large amount of the DPTP69D protein at a specific time during oogenesis. The transcript appears to be greatly reduced in concentration in the nurse cell cytoplasm by stage 11, suggesting that it is either rapidly transported to the oocyte, or it is degraded soon after its release into the cytoplasm. Thus the RNA is only detected in the nurse cell cytoplasm during a period of no more than 6 h during stages 10 and 11, indicating that translation of the gene product in the nurse cells is restricted to that time period. The most obvious event that is taking place at this time is the contraction of nurse cells, which results in the rapid transfer of most of their contents into the oocyte (reviewed by Mahajan-Miklos and Cooley, 1994) . We envision two plausable functions for DPTP69D at this critical phase of oogenesis: The protein may be required for the rapid dephosphorylation of some cytoplasmic component prior to the rapid transfer of the cytoplasm from the metabolically active nurse cells to the quiescent oocyte, or alternatively it may be required for the dephosphorylation of some component of the ring canal that may be required to allow the increased rate of cytoplasmic transfer to the oocyte during stages 11 and 12. This second possibility is consistent with the observation that anti-phosphotyrosine antibodies bind to one or more epitopes that are present in ring canals throughout oogenesis (Robinson et ai., 1994) .
Other PTPs may be transcribed in the ovaries
We do not expect that we have isolated all of the PTPs that are transcribed in the ovaries, and the use of different primers and PCR protocols has yielded different pools of PTPs (outlined in Section 2). Our primers in all cases were directed against highly conserved regions of previously identified PTPs; this will reduce the likelihood of isolating PTPs less conserved in these regions. In this respect it is significant that, although csw is obviously transcriptionally active during oogenesis, our PCR screens failed to isolate it. The genes stg and twe are also expressed in ovaries (Alphey et al., 1992; Courtot et al., 1992) , and neither of these PTPs were recovered in our screens.
DPTP99A is the only PTP we recovered for which we detect transcription in follicle cells, and its expression is not detected before stage 9. Our protocol may have disfavored the recovery of PTPs that are expressed in the follicle cells due to the excess volume of germline cells in the ovary. We do expect that PTPs are expressed in follicle cells during earlier stages of oogenesis, as top is required to influence the pattern of vitelline membrane synthesis, and there is some evidence that top is required much earlier, in the somatic cells of the germarium during egg chamber formation (Goode et al., 1992) . If PTPs are required in the TOP signaling pathway, we would have expected to detect expression in the somatic cells at earlier stages. Thus we suggest that a continued search, perhaps using somatic tissues, or early stage egg chambers, is likely to identify additional PTP genes that are expressed during oogenesis.
